Can warfarin (a vitamin K antagonist anticoagulant) cause sensorineural hearing loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Warfarin Cause Hearing Loss?

No, warfarin does not cause hearing loss—in fact, the evidence suggests that sudden sensorineural hearing loss (SSNHL) can occur when anticoagulation is inadequate or discontinued, not because of the warfarin itself.

Key Evidence from FDA Drug Labeling

The FDA-approved warfarin label does not list hearing loss, tinnitus, or any ototoxic effects as adverse reactions or contraindications 1. This is significant because if warfarin directly caused hearing loss, it would be documented in the official prescribing information after decades of widespread use.

Clinical Evidence: The Paradox of Anticoagulation

The relationship between warfarin and hearing loss is actually the opposite of causation:

When Hearing Loss Occurs During Anticoagulation

A study examining 10 patients who developed SSNHL while on warfarin therapy found that half had subtherapeutic anticoagulation (PT >30%) at the time of the hearing loss event 2. The authors concluded they could not demonstrate that warfarin caused the hearing loss, and suggested that inadequate anticoagulation may have allowed vascular compromise to occur.

When Anticoagulation is Protective

The most compelling evidence comes from a case report of a patient with antiphospholipid syndrome who developed SSNHL after discontinuing warfarin for several days 3. When warfarin was restarted, his hearing recovered within 3 days, with pure tone average improving from 73 dB to 12 dB. This demonstrates that warfarin withdrawal, not warfarin use, precipitated the hearing loss.

Anticoagulation as Treatment

A comparative study of 168 patients with sudden deafness found that anticoagulant therapy was effective treatment, particularly for low-frequency hearing losses 4. This further supports that anticoagulation helps rather than harms hearing in vascular-mediated cases.

The Vascular Mechanism

Vascular compromise (thrombosis, embolism, reduced blood flow, or vasospasm) is one of four recognized pathways leading to SSNHL 2. In patients requiring anticoagulation for underlying thrombotic conditions:

  • Adequate anticoagulation protects against cochlear vascular events
  • Inadequate or discontinued anticoagulation removes this protection and allows thrombotic events
  • The inner ear's microcirculation is particularly vulnerable to ischemic injury

Clinical Implications

If a patient on warfarin develops sudden hearing loss:

  1. Check the INR immediately—subtherapeutic anticoagulation may indicate inadequate protection against thrombosis
  2. Do not discontinue warfarin unless there is active bleeding or another absolute contraindication
  3. Obtain audiometry within 14 days to confirm SSNHL 5
  4. Consider the underlying indication for anticoagulation—conditions like antiphospholipid syndrome may directly cause SSNHL through thrombotic mechanisms 3
  5. Initiate corticosteroid therapy per standard SSNHL guidelines (systemic or intratympanic) 5

What Actually Causes Drug-Induced Hearing Loss

A comprehensive 2024 review of drug-induced hearing loss identified the main culprits as: immunosuppressants, antimalarials, vaccines, antibiotics, antineoplastic agents, diuretics, NSAIDs, and analgesics 6. Warfarin is notably absent from this list.

The 2019 AAO-HNS guidelines on sudden hearing loss specifically recommend against routine laboratory testing in SSNHL patients 5, as most cases are idiopathic and not related to identifiable drug causes.

Bottom Line

Warfarin does not cause hearing loss. Patients on warfarin who develop SSNHL likely have either: (1) inadequate anticoagulation allowing thrombotic events, (2) an underlying prothrombotic condition that warfarin is treating, or (3) idiopathic SSNHL unrelated to their anticoagulation. The evidence shows warfarin can be protective and therapeutic for vascular-mediated hearing loss, not causative.

References

Research

Sudden sensorineural hearing loss during oral anticoagulant therapy.

The Journal of laryngology and otology, 2004

Research

Sudden deafness: a comparison of anticoagulant therapy and carbogen inhalation therapy.

The Annals of otology, rhinology, and laryngology, 1997

Guideline

clinical practice guideline: sudden hearing loss (update).

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.